Literature DB >> 31386554

Cardiothoracic manifestations of Erdheim-Chester disease.

Jeeban Paul Das1, Lola Xie1, Chris C Riedl1, Sara A Hayes1, Michelle S Ginsberg1, Darragh F Halpenny1.   

Abstract

Erdheim-Chester disease (ECD) is a rare non-Langerhans cell histiocytosis which can have a broad range of clinical and radiological presentations. Typically, ECD affects multiple organ systems, with skeletal involvement present in almost all ECD patients and cardiothoracic manifestations in more than half. Cardiac and thoracic involvement contributes significantly to morbidity and mortality in affected patients and may have prognostic implications. The diagnosis of ECD can be challenging due to its rarity and similarity to other systemic disease processes. Although the diagnosis can be suggested on imaging, histopathology and immunohistochemistry are required for confirmation. We describe the multimodal imaging features of mediastinal, cardiac, pleural and lung parenchymal ECD. This review identifies the most common radiological manifestations of cardiac and thoracic ECD on contrast-enhanced CT, fluorine18-fludeoxyglucose positron emission tomography/CT and cardiac MRI, and highlights the role of these cross-sectional techniques in disease diagnosis.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31386554      PMCID: PMC6913371          DOI: 10.1259/bjr.20190473

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  15 in total

1.  Thoracic involvement in Erdheim-Chester disease: computed tomography imaging findings and their association with the BRAFV600E mutation.

Authors:  S Mojdeh Mirmomen; Arlene Sirajuddin; Moozhan Nikpanah; Rolf Symons; Anna K Paschall; Ioannis Papageorgiou; William A Gahl; Kevin O'Brien; Juvianee I Estrada-Veras; Ashkan A Malayeri
Journal:  Eur Radiol       Date:  2018-05-07       Impact factor: 5.315

2.  Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease.

Authors:  Eli L Diamond; Lorenzo Dagna; David M Hyman; Giulio Cavalli; Filip Janku; Juvianee Estrada-Veras; Marina Ferrarini; Omar Abdel-Wahab; Mark L Heaney; Paul J Scheel; Nancy K Feeley; Elisabetta Ferrero; Kenneth L McClain; Augusto Vaglio; Thomas Colby; Laurent Arnaud; Julien Haroche
Journal:  Blood       Date:  2014-05-21       Impact factor: 22.113

Review 3.  Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases.

Authors:  C Veyssier-Belot; P Cacoub; D Caparros-Lefebvre; J Wechsler; B Brun; M Remy; B Wallaert; H Petit; A Grimaldi; B Wechsler; P Godeau
Journal:  Medicine (Baltimore)       Date:  1996-05       Impact factor: 1.889

4.  18F-FDG PET/CT in Erdheim-Chester Disease: Imaging Findings and Potential BRAF Mutation Biomarker.

Authors:  Jason R Young; Geoffrey B Johnson; Robert C Murphy; Ronald S Go; Stephen M Broski
Journal:  J Nucl Med       Date:  2017-11-02       Impact factor: 10.057

5.  Pulmonary involvement with Erdheim-Chester disease: radiographic and CT findings.

Authors:  K H Wittenberg; S J Swensen; J L Myers
Journal:  AJR Am J Roentgenol       Date:  2000-05       Impact factor: 3.959

6.  Variability in the efficacy of interferon-alpha in Erdheim-Chester disease by patient and site of involvement: results in eight patients.

Authors:  Julien Haroche; Zahir Amoura; Salim G Trad; Bertrand Wechsler; Philippe Cluzel; Philippe A Grenier; Jean-Charles Piette
Journal:  Arthritis Rheum       Date:  2006-10

7.  Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.

Authors:  David M Hyman; Igor Puzanov; Vivek Subbiah; Jason E Faris; Ian Chau; Jean-Yves Blay; Jürgen Wolf; Noopur S Raje; Eli L Diamond; Antoine Hollebecque; Radj Gervais; Maria Elena Elez-Fernandez; Antoine Italiano; Ralf-Dieter Hofheinz; Manuel Hidalgo; Emily Chan; Martin Schuler; Susan Frances Lasserre; Martina Makrutzki; Florin Sirzen; Maria Luisa Veronese; Josep Tabernero; José Baselga
Journal:  N Engl J Med       Date:  2015-08-20       Impact factor: 91.245

8.  Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet.

Authors:  Gethin Williams; Gerald M Kolodny
Journal:  AJR Am J Roentgenol       Date:  2008-02       Impact factor: 3.959

Review 9.  The histopathology of Erdheim-Chester disease: a comprehensive review of a molecularly characterized cohort.

Authors:  Neval Ozkaya; Marc K Rosenblum; Benjamin H Durham; Janine D Pichardo; Omar Abdel-Wahab; Meera R Hameed; Klaus J Busam; William D Travis; Eli L Diamond; Ahmet Dogan
Journal:  Mod Pathol       Date:  2017-12-01       Impact factor: 7.842

10.  Clinical and Histopathologic Features of Interstitial Lung Disease in Erdheim⁻Chester Disease.

Authors:  Sara G Haroutunian; Kevin J O'Brien; Juvianee I Estrada-Veras; Jianhua Yao; Louisa C Boyd; Kavya Mathur; William A Gahl; S Mojdeh Mirmomen; Ashkan A Malayeri; David E Kleiner; Elaine S Jaffe; Bernadette R Gochuico
Journal:  J Clin Med       Date:  2018-08-28       Impact factor: 4.241

View more
  2 in total

1.  Pericardiectomy for Constrictive Pericarditis in a Young Patient With Erdheim-Chester Disease.

Authors:  Ryaan El-Andari; Abdullah Baghaffar; Andrew O'Connell; Jimmy J H Kang; Jean Deschenes; Anthony George; Michael C Moon
Journal:  JACC Case Rep       Date:  2022-07-20

2.  Cardiac electrical instability in Erdheim-Chester disease: a case report.

Authors:  Andrea Urbani; Filippo Pensotti; Diego Castini; Silvia Magnani; Pasquale Simone Simeoli; Corrado Campochiaro; Lorenzo Dagna; Alberto M Cappelletti; Carlo Sponzilli; Marco Guazzi
Journal:  Oxf Med Case Reports       Date:  2022-07-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.